JEREMY WALSTON, M.D.
Osteopathic Medicine at Hopkins Bayview Cir, Baltimore, MD

License number

Maryland D38849

Personal information

See more information about JEREMY WALSTON at radaris.com

Name

Address

Phone

Jeremy D Walston, age 63

126 Lafayette Ave, Baltimore, MD 21217

(410) 523-8391

Jeremy D Walston, age 63

1305 Park Ave, Baltimore, MD 21217

(410) 523-8391

Jeremy D Walston, age 63

1305 Park Ave, Baltimore, MD 21217

(410) 523-8391

Jeremy D Walston

1303 Park Ave, Baltimore, MD 21217

(410) 523-8391

Jeremy D Walston, age 63

127 Lafayette Ave, Baltimore, MD 21217

Organization information

See more information about JEREMY WALSTON at bizstanding.com

Jeremy Walston MD

5505 Hopkins Bayview Cir, Baltimore, MD 21224

Industry:

Geriatrics, Internist

Phone:

(410) 550-0925 (Phone)

Jeremy David Walston

Professional information

Dr. Jeremy Walston, Baltimore MD - MD (Doctor of Medicine)

Specialties:

Geriatric Medicine

Address:

The Beacham Ambulatory Clinic
5505 Hopkins Bayview Cir, Baltimore 21224
(410) 550-6147 (Phone)

Certifications:

Geriatric Medicine, 1994, Internal Medicine, 2012

Awards:

Healthgrades Honor Roll

Languages:

English

Hospitals:

The Beacham Ambulatory Clinic
5505 Hopkins Bayview Cir, Baltimore 21224
Johns Hopkins Bayview Medical Center
4940 Eastern Ave, Baltimore 21224

Education:

Medical School
University Of Cincinnati College Of Medicine
Graduated: 1988
Johns Hopkins Bayview M C
Johns Hopkins Hospital

Jeremy David Walston, Baltimore MD

Specialties:

Internal Medicine, Geriatric Medicine

Work:

Johns Hopkins Bayview Medical Center
5501 Hopkins Bayview Cir, Baltimore, MD 21224

Education:

University of Cincinnati (1988)

Novel, Protective, Anti-Inflammatory Receptor And Its Use In Preservation Of Mitochondrial Function, Wound Healing And Repair

US Patent:

2014005, Feb 27, 2014

Filed:

Mar 30, 2012

Appl. No.:

14/008585

Inventors:

Peter M. Abadir - Woodstock MD, US
Jeremy D. Walston - Baltimore MD, US

Assignee:

The Johns Hopkins University - Baltimore MD

International Classification:

G01N 33/566, A61K 31/4184, A61K 31/4178, A61K 31/41

US Classification:

514381, 514394, 514397, 435 29, 435375

Abstract:

Provided herein is a novel mitochondrial Angiotensin II type 1 and type 2 ATR and ATR receptor which plays a role in protection of mitochondria against oxidative damage. Evidence from animal studies indicates a role for this receptor in preservation of mitochondria and up-regulation of survival genes, anti-inflammatory action, and improvement of wound healing in the skin and soft tissues. Pharmaceutical compositions for treatment directed to preserving mitochondrial function, anti-inflammation, wound healing and decreasing the signs of aging, as well as medicaments and their use are also provided.

Treatment Modalities To Prevent Or Treat Loss Of Cardiovascular Function In Aging Humans

US Patent:

2013012, May 16, 2013

Filed:

Nov 12, 2012

Appl. No.:

13/674197

Inventors:

The Johns Hopkins University - Baltimore MD, US
Dan E. Berkowitz - Baltimore MD, US
Lili Ayala Barouch - Ellicott City MD, US
Jeremy D. Walston - Baltimore MD, US

Assignee:

THE JOHNS HOPKINS UNIVERSITY - Baltimore MD

International Classification:

C12Q 1/02

US Classification:

424 852, 435 29

Abstract:

Provided herein are methods for treating, preventing or reducing age related vascular stiffness and impaired cardiovascular function in a subject comprising administering to the subject a therapeutic amount of IL-10 or an IL-10 agonist or pharmaceutical compositions comprising the same. Also included herein are methods for determining whether a biologically active agent can treat, prevent or reduce age related vascular stiffness and impaired cardiovascular function using an in vitro model in a IL-10 knockout IL-10(tm/tm) mouse which lacks IL-10 function.

Susceptibility Gene For Obesity And Type Ii Diabetes Mellitus

US Patent:

5766851, Jun 16, 1998

Filed:

May 19, 1995

Appl. No.:

8/446530

Inventors:

Alan R. Shuldiner - Columbia MD
Jeremy Walston - Baltimore MD
Kristi Silver - Baltimore MD
Jesse Roth - Baltimore MD

Assignee:

The Johns Hopkins University School of Medicine - Baltimore MD

International Classification:

C12Q 168, C12P 1934, C07H 2104

US Classification:

435 6

Abstract:

The present invention provides a novel polypeptide characterized by a non-conservative missense mutation, Trp64Arg, in the. beta. 3-adrenergic receptor (. beta. 3AR) that increases susceptibility to obesity and non-insulin dependent diabetes mellitus (NIDDM; type II diabetes). Also provided are methods of diagnosis and methods of treatment of subjects having or at risk of having type II diabetes/obesity.